VIGAMOX gtt opht fl 5 ml

7680573490045 CH-57349 S01AE07 11.07.1.
VIGAMOX gtt opht fl 5 ml
VIGAMOX gtt opht fl 5 ml
VIGAMOX gtt opht fl 5 ml
1 / 3
google

Details

Product number
5734901
CPT
-
Packaging group
5
Unit
ml
Composition
moxifloxacinum 5 mg ut moxifloxacini hydrochloridum 5.45 mg, natrii chloridum, acidum boricum, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, ad solutionem pro 1 ml.

Articles (1)

Vigamox, Augentropfen
Augentropfen
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/09/2020
Patient information leaflet
Français
29/09/2020
Patient information leaflet
Italien
29/09/2020
Professional SmPC
Allemand
29/09/2020
Professional SmPC
Français
29/09/2020
Professional SmPC
Italien
29/09/2020

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.45 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 17.35
Specialties list
Yes
Generic
No
SL addition date: 01/07/2008

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
57349
Drug name
Vigamox, Augentropfen
Galenic form
AUGT
ATC Code
S01AE07
Authorization status
Z
Dispensation category
A
First authorization
14/10/2005
Authorization expiration date
31/12/9999
IT number
11.07.1.
Domain
Human medicine
Field of application
Bakterielle Infektionen des vorderen Augenabschnittes

Packaging details

Description (FR)
VIGAMOX gtt opht fl 5 ml
Description (DE)
VIGAMOX Gtt Opht Fl 5 ml
Market launch
14/10/2005
Narcotic (BTM)
No

Other packaging sizes